|
|
|
|
JAG Media Holdings, Inc. Announces a Further Update of the Status of Its Acquisition of CardioGenics Inc
BOCA RATON, Fla., June 30 /PRNewswire-FirstCall/ -- JAG Media Holdings, Inc.announced today a further update of the status of its acquisition of CardioGenics Inc. by its Ontario, Canada subsidiary, CardioGenics ExchangeCo.
|
|
|
NEJM: Early PCI after fibrinolysis benefits STEMI patients
Among high-risk STEMI patients, who were treated with fibrinolysis, transfer for PCI within six hours after fibrinolysis was associated with significantly fewer ischemic complications than was standard treatment, according to the TRANSFER...
|
|
|
Immediate Transfer for PCI Beneficial After Fibrinolysis for STEMI
Patients experiencing ST-segment elevation myocardial infarction (STEMI) who are treated with fibrinolysis fare better if they are transferred for routine percutaneous coronary intervention (PCI) within 6 hours of the therapy.Immediate...
|
|
|
TRANSFER AMI published: Finding the optimal window for PCI postlysis
Newmarket, ON - The TRANSFER AMI trial, showing that STEMI patients treated with fibrinolysis had better outcomes if they were transferred for PCI within six hours, has now been published in the June 25, 2009 issue of the New England Journal...
|
|
|
TRANSFER-AMI results supporting early PCI after fibrinolysis published
MedWire News: TRANSFER-AMI results reported in the current issue of the New England Journal of Medicine support a benefit of routine early percutaneous coronary intervention (PCI) compared with an ischemia-driven strategy after initial...
|
|
|
ACC/AHA guideline update for the management of ST-segment elevation myocardial infarction
(Click the title below to leave the MDLinx Network and go to the Journal's Website) American Family Physician, 06/16/09 Print Save in My Library Free Abstract Campbell-Scherer DL et al.- Early recognition and prompt initiation of...
|
|
|
Thromboembolic risk may guide OAT bridging therapy
MedWire News: Low molecular weight heparin (LMWH) bridging therapy for oral anticoagulation therapy (OAT) outpatients undergoing surgery can be tailored using individual risk for thromboembolism, Italian researchers say.The team assessed...
|
|
|
Bracco debuts new CardioGen pump at SNM show
Case of the Day and Teaching Files Focused topics digital communities Lively, discussion groups Comprehensive buyer''s guide Medical imaging bookstore SalaryScan Job Boards OnLine CMe/CE Bookstore, market reports, more Conference Calend...
|
|
|
MDS Nordion Begins to Manufacture Cardiac Imaging Agent
Bracco's Cardiogen-82(R) Enables Cardiologists to Better Detect Cardiovascular Disease OTTAWA, June 10 /PRNewswire-FirstCall/ - MDS Nordion, a leading provider of medical isotopes and radiopharmaceuticals, today announced...
|
|
|
MDS Nordion Manufactures CardioGen-82 Cardiac Imaging Agent
MDS Nordion said today that it commenced the manufacture of CardioGen-82 (rubidium Rb 82 generators) for Bracco Diagnostics, Inc.CardioGen-82, the only generator-based, cardiac Positron Emission Tomography (PET) perfusion...
|
|
|
MDS Nordion Initiates Manufacture Of Cardiac Imaging Agent
CardioGen-82, generator-based, cardiac Positron Emission Tomography Suppliers to this Sector From the control room to the downstream processing ...Independent QA for Therapeutic Radiology and Oncol ... It is our mission to...
|
|
|
Acute myocardial infarction with cardiogenic shock on admission: Incidence, prognostic implications, and curre
(Click the title below to leave the MDLinx Network and go to the Journal's Website) Herz, 06/11/09 Print Save in My Library Free Abstract Beermann W et al.- The in-hospital mortality in patients with CS receiving thrombolytic therapy was...
|
|
|
MDS Nordion Begins to Manufacture Cardiac Imaging Agent
<< Bracco's Cardiogen-82(R) Enables Cardiologists to Better Detect Cardiovascular Disease >> OTTAWA, June 10 /CNW/ - MDS Nordion, a leading provider of medical isotopes and radiopharmaceuticals, today announced that it has...
|
|
|
MDS begins CardioGen-82 production
Case of the Day and Teaching Files Focused topics digital communities Lively, discussion groups Comprehensive buyer''s guide Medical imaging bookstore SalaryScan Job Boards OnLine CMe/CE Bookstore, market reports, more Conference Calend MDS...
|
|
|
Coronary aneurysm after DES implantation rare
MedWire News: Coronary aneurysms (CANs) are rare after drug-eluting stent (DES) implantation and detectable in asymptomatic patients, conclude Spanish researchers who nevertheless warn such complications may be linked to stent restenosis and...
|
|
|
JAG Media Holdings to acquire CardioGenics
JAG Media Holdings, Inc., a US-based provider of internet-based equities information, through its newly created Canadian subsidiary, CardioGenics Exchangeco, Inc.(Exchangeco), has entered into a definitive share purchase agreement...
|
|
|
deCODE, Celera tie up to expand use of deCODE risk markers for heart attack, stroke & diabetes
deCODE genetics and Celera Corporation announced the signing of agreements under which deCODE has granted Celera non-exclusive worldwide licenses to deCODE's genetic markers for increased risk of major cardiovascular and metabolic diseases,...
|
|
|
deCODE and Celera Partner to Expand Use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes
REYKJAVIK, Iceland & ALAMEDA, Calif.--(BUSINESS WIRE)--deCODE genetics (NASDAQ:DCGN - News) and Celera Corporation (NASDAQ:CRA - News) today announced the signing of agreements under which deCODE has granted Celera non-exclusive...
|
|
|
deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes
REYKJAVIK, Iceland, and ALAMEDA, California, April 23 /PRNewswire-FirstCall/ -- deCODE genetics (NASDAQ:DCGN - News) and Celera Corporation (NASDAQ:CRA - News) today announced the signing of agreements under which deCODE has granted Celera...
|
